2021
DOI: 10.1126/scitranslmed.abh4284
|View full text |Cite|
|
Sign up to set email alerts
|

Restoring activity in the thalamic reticular nucleus improves sleep architecture and reduces Aβ accumulation in mice

Abstract: Chemogenetic stimulation of the thalamic reticular nucleus increases slow-wave sleep and reduces Aβ accumulation in rodents.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 85 publications
0
4
0
Order By: Relevance
“…For example, one night of sleep deprivation in humans significantly increased detectable Aβ levels in the brain (Shokri-Kojori et al, 2018), slow-wave sleep disruption increased Aβ levels in the CSF (Ju et al, 2017), and chronic sleep restriction in mouse AD models (Kang et al, 2009) or rats (Zhao et al, 2019) increased Aβ plaque accumulation. Conversely, pharmacologically or optogenetically improving sleep in mouse models of AD reduced the overall lifetime Aβ plaque burden (Jagirdar et al, 2021; Kang et al, 2009). Together, these observations have led to the proposal that sleep and Aβ dynamics create a positive feedforward cycle, wherein increases in wakefulness result in increased extracellular Aβ and aggregation, which then dysregulates sleep, further exacerbating the creation of pathogenic Aβ production (Ju et al, 2014; Roh et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…For example, one night of sleep deprivation in humans significantly increased detectable Aβ levels in the brain (Shokri-Kojori et al, 2018), slow-wave sleep disruption increased Aβ levels in the CSF (Ju et al, 2017), and chronic sleep restriction in mouse AD models (Kang et al, 2009) or rats (Zhao et al, 2019) increased Aβ plaque accumulation. Conversely, pharmacologically or optogenetically improving sleep in mouse models of AD reduced the overall lifetime Aβ plaque burden (Jagirdar et al, 2021; Kang et al, 2009). Together, these observations have led to the proposal that sleep and Aβ dynamics create a positive feedforward cycle, wherein increases in wakefulness result in increased extracellular Aβ and aggregation, which then dysregulates sleep, further exacerbating the creation of pathogenic Aβ production (Ju et al, 2014; Roh et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Although the exact mechanism of sleep disturbance involved in cognitive impairment has not been fully determined. A growing number of studies have found that sleep disorders may lead to cognitive impairment and accelerate AD pathology, including increased Aβ deposition in the brain [42][43][44][45][46][47][48]. Our recent studies also showed that sleep deprivation induced peripheral Aβ transport dysfunction in young adults, and Aβ accumulation in the brain in rats [49,50].…”
Section: Discussionmentioning
confidence: 65%
“…In wild-type rats and mice overexpressing mutated human APP and PSEN1 , restricting sleep for 21 days increased Aβ deposits in the cortex 67,68 . Conversely, pharmaceutically or chemogenetically consolidating sleep in AD mouse models for 1–2 months delayed Aβ plaque formation 67,69 . Disrupted sleep is therefore likely to be a causal process in AD.…”
Section: Discussionmentioning
confidence: 99%